Pernix Therapeutics Holdings Inc (PTXTQ)
followers
·
Follow
Sector:
REAL ESTATE
Industry:
REAL ESTATE INVESTMENT TRUSTS
SIC:
LAND SUBDIVIDERS & DEVELOPERS (NO CEMETERIES)
CEO:
John A. Sedor
Employees:
185
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NJ, 07960
(862) 260-8457
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Date | Ratio |
---|---|
2010-03-10 | 1:2 |
2016-10-14 | 1:10 |
Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. The firm distributes its products under the following brands: Treximet, Silenor, Zohydro ER with BeadTek, and Khedezla. The company was founded on March 9, 2010 and is headquartered in The Woodlands, TX.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|